Living Peptide Status Tracker
Peptide status tracker
A source-backed tracker for observed federal FDA peptide status facts. Rows state what has been observed, not whether a product may be compounded.
Observed Status Rows
Status labels combine narrow source-backed events. They are not legal or medical recommendations.
KPV
MOTs-C
TB-500
DSIP / Emideltide
Epitalon
Semax
DiHexa
Events
-
Category 2 Status
Forms and confidence
Evidence
Support1 reference
Fact IDs
DiHexa
fact:4f383f68-1875-486c-8515-b62ffb6de72eSourceGHK-Cu
Events
-
Category 2 Status
Forms and confidence
Evidence
Support1 reference
Fact IDs
GHK-Cu
fact:0d823586-a361-4a95-8658-92d29d086f75SourceLL-37
Events
-
Category 2 Status
Forms and confidence
Evidence
Support1 reference
Fact IDs
LL-37
fact:24109c3e-9e8a-412a-a4fb-e5b7dd534924SourceMelanotan II
Events
-
Category 2 Status
Forms and confidence
Evidence
Support1 reference
Fact IDs
Melanotan II
fact:f290fed9-8a84-4462-809c-76b2cc810a92SourcePEG-MGF
Events
-
Category 2 Status
Forms and confidence
Evidence
Support1 reference
Fact IDs
PEG-MGF
fact:96f186de-0236-4385-afb2-512a7428e7a1SourceClaim Map
Scope claims are rendered with support because they materially affect how the tracker should be interpreted.
Tracker Scope
The tracker currently contains verified Category 2 removal facts for twelve named peptides.
Support12 references
Fact IDs
BPC-157
fact:be4c8c0a-6dfc-4487-94c2-b4243ef9c7c1SourceDiHexa
fact:4f383f68-1875-486c-8515-b62ffb6de72eSourceDSIP
fact:797071cd-cd16-4d40-b5ef-f6d7716be17bSourceEpitalon
fact:c0e7a5ad-5ac1-46a6-81b9-aa94429925ffSourceGHK-Cu
fact:0d823586-a361-4a95-8658-92d29d086f75SourceKPV
fact:ad3735b4-44d3-49ff-bd2f-20289fdb11caSourceLL-37
fact:24109c3e-9e8a-412a-a4fb-e5b7dd534924SourceMelanotan II
fact:f290fed9-8a84-4462-809c-76b2cc810a92SourceMOTs-C
fact:69f9419b-4ba9-4cec-891d-64a559c5b1c3SourcePEG-MGF
fact:96f186de-0236-4385-afb2-512a7428e7a1SourceSemax
fact:adf1fa3a-fc99-47df-9b95-d12d6622b1faSourceTB-500
fact:4a490e1f-b497-481f-b5a1-285ce8cd0ad9SourceThe tracker currently contains verified PCAC agenda-inclusion facts for seven peptide entries.
Support7 references
Fact IDs
BPC-157
fact:f3f9071e-cb4d-4926-b4b5-40bb68bf022bSourceEmideltide / DSIP
fact:f6f69a5c-be84-4b94-840d-50b0668facc6SourceEpitalon
fact:6d0034db-eb61-4e11-8372-967967feb1eeSourceKPV
fact:65fcf810-01cb-4d75-8c17-222e6b898992SourceMOTs-C
fact:16bf8e4c-e6c0-4cca-b733-0f00afd98f7fSourceSemax
fact:4e99f540-ad6f-4046-a0a2-418f8b905ed1SourceTB-500
fact:90bf704e-9ae3-4e74-9736-f3c15722abb8SourceA tracker row should not be read as FDA approval, final 503A bulks-list inclusion, or permission to compound.
Support19 references
Fact IDs
BPC-157
fact:be4c8c0a-6dfc-4487-94c2-b4243ef9c7c1SourceBPC-157
fact:f3f9071e-cb4d-4926-b4b5-40bb68bf022bSourceDiHexa
fact:4f383f68-1875-486c-8515-b62ffb6de72eSourceDSIP
fact:797071cd-cd16-4d40-b5ef-f6d7716be17bSourceEmideltide / DSIP
fact:f6f69a5c-be84-4b94-840d-50b0668facc6SourceEpitalon
fact:c0e7a5ad-5ac1-46a6-81b9-aa94429925ffSourceEpitalon
fact:6d0034db-eb61-4e11-8372-967967feb1eeSourceGHK-Cu
fact:0d823586-a361-4a95-8658-92d29d086f75SourceKPV
fact:ad3735b4-44d3-49ff-bd2f-20289fdb11caSourceKPV
fact:65fcf810-01cb-4d75-8c17-222e6b898992SourceLL-37
fact:24109c3e-9e8a-412a-a4fb-e5b7dd534924SourceMelanotan II
fact:f290fed9-8a84-4462-809c-76b2cc810a92SourceMOTs-C
fact:69f9419b-4ba9-4cec-891d-64a559c5b1c3SourceMOTs-C
fact:16bf8e4c-e6c0-4cca-b733-0f00afd98f7fSourcePEG-MGF
fact:96f186de-0236-4385-afb2-512a7428e7a1SourceSemax
fact:adf1fa3a-fc99-47df-9b95-d12d6622b1faSourceSemax
fact:4e99f540-ad6f-4046-a0a2-418f8b905ed1SourceTB-500
fact:4a490e1f-b497-481f-b5a1-285ce8cd0ad9SourceTB-500
fact:90bf704e-9ae3-4e74-9736-f3c15722abb8Source